WithdrawnPhase 2

Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma Exacerbations

Stopped: Diminished minimum sample size needed to detect any effect of the intervention due to TwiCs study design, control arm participants were already recruited to the parent study (COVIDENCE UK).

United Kingdom0Started 2025-03-27

Plain-language summary

REMASK trial is a Trial within Cohort study (TwiCs), nested within the COVIDENCE UK longitudinal study. It has been designed to determine whether the offer of a free reusable, elastomeric face mask to adults with asthma and other members of their household reduces risk of RT-PCR confirmed viral respiratory infections and asthma exacerbations.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Eligibility criteria, participants with asthma ('index participants'): Inclusion Criteria: * Aged 16 or more years * Doctor diagnosis of asthma * Current prescription for treatment of asthma * Participant in COVIDENCE UK nasal swab study Exclusion Criteria: * Regularly using any FFP-rated face mask when in an indoor public place * Currently sharing household with one or more children * Currently sharing household with one or more other COVIDENCE UK participants who have asthma * Unable to tolerate wearing face mask Eligibility criteria, household members of index participants: Inclusion criteria * Age 16 or more * Living in same household as index participant who has consented to take part in trial Exclusion criteria \- Unable to tolerate wearing face mask

What they're measuring

Time to first RT-PCR-proven viral respiratory infection

Timeframe: 12 months

Trial details

NCT IDNCT06885229

SponsorQueen Mary University of London

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-01

View on ClinicalTrials.gov More Acute Respiratory Infection trials